Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients

Silvia Milena Becerra Bayona; Claudia Lucia Sossa Melo; ligia cecilia  mateus caicedo; Martha Ligia Arango Rodríguez; Miguel Enrique Ochoa Vera

Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients

Silvia Milena Becerra Bayona, Claudia Lucia Sossa Melo, ligia cecilia mateus caicedo, Martha Ligia Arango Rodríguez, Miguel Enrique Ochoa Vera

Producción científica: Eventos › Eventos científicos › revisión exhaustiva

Idioma original	Inglés estadounidense
Estado	Publicada - 2023
Evento	49th Annual Meeting of the EBMT - Paris, Francia Duración: 23 abr. 2023 → …

Taller

Taller	49th Annual Meeting of the EBMT
País/Territorio	Francia
Ciudad	Paris
Período	23/04/23 → …

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Citar esto

Becerra Bayona, S. M., Sossa Melo, C. L., mateus caicedo, L. C., Arango Rodríguez, M. L., & Ochoa Vera, M. E. (2023). Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients. Papel presentado en 49th Annual Meeting of the EBMT , Paris, Francia.

Becerra Bayona, Silvia Milena ; Sossa Melo, Claudia Lucia ; mateus caicedo, ligia cecilia et al. / Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients. Papel presentado en 49th Annual Meeting of the EBMT , Paris, Francia.

@conference{61aafcbbc69347538d8819baa59e7d66,

title = "Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients",

author = "{Becerra Bayona}, {Silvia Milena} and {Sossa Melo}, {Claudia Lucia} and {mateus caicedo}, {ligia cecilia} and {Arango Rodr{\'i}guez}, {Martha Ligia} and {Ochoa Vera}, {Miguel Enrique}",

year = "2023",

language = "American English",

note = "49th Annual Meeting of the EBMT ; Conference date: 23-04-2023",

}

Becerra Bayona, SM , Sossa Melo, CL, mateus caicedo, LC, Arango Rodríguez, ML & Ochoa Vera, ME 2023, 'Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients', Papel presentado en 49th Annual Meeting of the EBMT , Paris, Francia, 23/04/23.

Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients. / Becerra Bayona, Silvia Milena ; Sossa Melo, Claudia Lucia; mateus caicedo, ligia cecilia et al.
2023. Papel presentado en 49th Annual Meeting of the EBMT , Paris, Francia.

Producción científica: Eventos › Eventos científicos › revisión exhaustiva

TY - CONF

T1 - Exploring the therapeutic potential of autologous bone marrow mononuclear cells versus allogenic wharton jelly-derived mesenchymal stem cells in chronic limb-threatening ischemia in diabetic patients

AU - Becerra Bayona, Silvia Milena

AU - Sossa Melo, Claudia Lucia

AU - mateus caicedo, ligia cecilia

AU - Arango Rodríguez, Martha Ligia

AU - Ochoa Vera, Miguel Enrique

PY - 2023

Y1 - 2023

M3 - Scientific events

T2 - 49th Annual Meeting of the EBMT

Y2 - 23 April 2023

ER -